Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.40 | -8.44 | -9.11 | 40.27% | CHEMBL321190 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.11 | -8.29 | N/A | 50.71% | CHEMBL1802360 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -7.97 | -9.04 | -8.35 | 43.31% | CHEMBL51 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.96 | -8.80 | N/A | 48.48% | CHEMBL219916 |
AA1R_HUMAN | adenosine A1 receptor | -8.44 | -9.22 | -5.34 | 49.06% | CHEMBL559990 |
AA2AR_HUMAN | adenosine A2a receptor | -8.66 | -9.14 | -8.71 | 49.06% | CHEMBL559990 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.77 | -9.87 | -9.00 | 45.96% | CHEMBL1773485 |
ACE_HUMAN | angiotensin I converting enzyme | -8.00 | -8.88 | -7.13 | 44.17% | CHEMBL3414811 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.70 | N/A | N/A | 23.83% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -3.29 | -5.16 | -4.05 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -4.79 | 5.46 | N/A | 51.11% | CHEMBL2059304 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -6.13 | -5.88 | N/A | 49.19% | CHEMBL2146597 |
ADRB2_HUMAN | adrenoceptor beta 2 | -7.91 | -7.81 | -8.40 | 42.69% | CHEMBL1528906 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -8.66 | -8.47 | -8.26 | 33.33% | CHEMBL288705 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.83 | -8.35 | -7.61 | 35.71% | CHEMBL10413 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.39 | -8.50 | -7.99 | 28.03% | CHEMBL2332527 |
AOFA_HUMAN | monoamine oxidase A | -8.72 | -8.43 | -6.36 | 36.96% | CHEMBL1645548 |
AOFB_HUMAN | monoamine oxidase B | -7.97 | -8.53 | -7.01 | 44.07% | CHEMBL2312975 |
BACE1_HUMAN | beta-secretase 1 | -7.48 | -7.96 | -7.95 | 35.90% | CHEMBL1923753 |
CAH2_HUMAN | carbonic anhydrase 2 | -8.03 | -8.09 | -7.89 | 45.34% | CHEMBL3827113 |
CASP1_HUMAN | caspase 1 | -6.11 | -7.06 | -6.27 | 42.76% | CHEMBL1221646 |
CDK5_HUMAN | cyclin dependent kinase 5 | -6.92 | -7.56 | -6.73 | 34.72% | CHEMBL1994956 |
CHLE_HUMAN | butyrylcholinesterase | -9.09 | -9.38 | -8.77 | 43.36% | CHEMBL452339 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.42 | -9.29 | -10.36 | 51.75% | CHEMBL527071 |
CNR2_HUMAN | cannabinoid receptor 2 | -8.50 | -9.37 | N/A | 54.86% | CHEMBL498152 |
COLI_HUMAN | proopiomelanocortin | -7.82 | -7.25 | -8.10 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.76 | -6.42 | -7.00 | 32.69% | CHEMBL3980370 |
CRP_HUMAN | C-reactive protein | -6.25 | -6.07 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -0.64 | N/A | N/A | 21.76% | CHEMBL3609011 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -7.98 | -7.24 | -7.22 | 38.36% | CHEMBL853 |
DRD2_HUMAN | dopamine receptor D2 | -8.01 | N/A | N/A | 51.11% | CHEMBL2059304 |
DRD3_HUMAN | dopamine receptor D3 | -8.05 | N/A | N/A | 50.71% | CHEMBL1802360 |
DRD4_HUMAN | dopamine receptor D4 | -8.19 | -7.93 | N/A | 43.31% | CHEMBL51 |
EDN1_HUMAN | endothelin 1 | -7.31 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -5.57 | -7.85 | -6.42 | 41.46% | CHEMBL1395826 |
FABP5_HUMAN | fatty acid binding protein 5 | -8.04 | -6.19 | -5.96 | 27.60% | CHEMBL3950316 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -7.38 | N/A | N/A | 43.03% | CHEMBL3335371 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.39 | -8.43 | -8.32 | 19.68% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.43 | N/A | N/A | 19.68% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -4.10 | -2.52 | -2.99 | 39.35% | CHEMBL1682808 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.94 | -6.77 | -5.85 | 31.07% | CHEMBL3425948 |
HRH1_HUMAN | histamine receptor H1 | -6.85 | N/A | N/A | 48.48% | CHEMBL219916 |
HYES_HUMAN | epoxide hydrolase 2 | -8.77 | -8.70 | -8.02 | 40.00% | CHEMBL397694 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -7.85 | N/A | N/A | 34.23% | CHEMBL484012 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.01 | -7.67 | N/A | 48.48% | CHEMBL219916 |
MIF_HUMAN | macrophage migration inhibitory factor | -5.79 | -6.07 | -6.28 | 29.35% | CHEMBL3943378 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -7.09 | -7.88 | -7.27 | 39.78% | CHEMBL1230122 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -7.80 | -8.21 | -7.98 | 33.56% | CHEMBL29197 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.66 | -9.00 | -8.18 | 45.68% | CHEMBL3681182 |
NEP_HUMAN | membrane metalloendopeptidase | -6.96 | -7.22 | -6.93 | 36.20% | CHEMBL213944 |
NK1R_HUMAN | tachykinin receptor 1 | -8.21 | -8.59 | -8.30 | 48.41% | CHEMBL2313631 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.61 | -8.39 | -7.74 | 14.84% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -8.00 | -8.79 | -8.37 | 38.85% | CHEMBL3797704 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.60 | -8.35 | -7.74 | 29.76% | CHEMBL354003 |
NOS1_HUMAN | nitric oxide synthase 1 | -8.32 | -8.50 | -7.62 | 34.33% | CHEMBL3217000 |
NOS2_HUMAN | nitric oxide synthase 2 | -6.92 | -7.77 | -7.01 | 33.70% | CHEMBL387348 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -9.41 | -7.54 | -8.62 | 36.46% | CHEMBL3673446 |
OPRD_HUMAN | opioid receptor delta 1 | -7.39 | -6.86 | -6.80 | 48.63% | CHEMBL427683 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.26 | -7.71 | -7.71 | 52.42% | CHEMBL146013 |
OPRM_MOUSE | Mu-type opioid receptor | -8.46 | -7.72 | N/A | 30.18% | CHEMBL2419123 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.15 | -7.22 | -7.45 | 57.04% | CHEMBL1080485 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -5.85 | -5.71 | -6.04 | 40.72% | CHEMBL3948852 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -7.30 | -5.62 | -7.62 | 47.40% | CHEMBL91044 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -6.25 | N/A | N/A | 43.33% | CHEMBL95359 |
PDE4B_HUMAN | phosphodiesterase 4B | -8.26 | -8.49 | -8.97 | 50.60% | CHEMBL3938524 |
PDE5A_HUMAN | phosphodiesterase 5A | -7.96 | -8.47 | -8.04 | 41.46% | CHEMBL144400 |
PERM_HUMAN | myeloperoxidase | -8.17 | -8.34 | -8.57 | 39.46% | CHEMBL1409565 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -5.60 | -6.31 | -5.49 | 33.51% | CHEMBL421385 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -2.77 | -4.59 | -6.63 | 35.26% | CHEMBL97411 |
PPAP_HUMAN | acid phosphatase 3 | -7.96 | N/A | N/A | 17.50% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -7.71 | -6.96 | -8.06 | 46.07% | CHEMBL1946567 |
PRGR_HUMAN | progesterone receptor | -8.80 | -8.13 | -9.15 | 44.22% | CHEMBL188228 |
PTGES_HUMAN | prostaglandin E synthase | -5.79 | N/A | N/A | 37.66% | CHEMBL3770411 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -9.01 | -9.11 | -9.18 | 44.68% | CHEMBL514193 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.60 | N/A | N/A | 36.56% | CHEMBL3941343 |
TLR4_HUMAN | toll like receptor 4 | -8.16 | -7.59 | -7.66 | 37.78% | CHEMBL1223752 |
TNFA_HUMAN | tumor necrosis factor | -7.71 | N/A | N/A | 56.93% | CHEMBL3944621 |
TRBM_HUMAN | thrombomodulin | -7.33 | -8.37 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.51 | -6.59 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -8.61 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.71 | N/A | N/A | 32.37% | CHEMBL436839 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.15 | -6.67 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.12 | -6.57 | N/A | 29.51% | CHEMBL3664218 |
TRXR1_HUMAN | thioredoxin reductase 1 | -7.95 | -7.59 | -6.66 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -5.94 | N/A | N/A | 40.80% | CHEMBL25184 |